CMS’s announcement of an Advanced Notice of Proposed Rulemaking with Comment proposes to implement an international pricing index model for Medicare Part B drugs and biologicals. This model has the potential to make changes to the entire pharma ecosystem.
McDermottPlus breaks down the MPFS Final Rule, providing the top 10 takeaways for your reading pleasure.
Democrats will take control of the House of Representatives in January. Republicans will retain control of the Senate. Split control of Congress will have important consequences for healthcare policy. This article examines the elections impact on the agenda.
McDermottPlus persuaded the Centers for Medicare and Medicaid Services (CMS) to revise Medicare laboratory “Date of Service” regulations.
Codes currently eligible for exception to DOS rule
McDermottPlus assessed the policy pathway and operational feasibility to scale up group prenatal care, and designed alternative payment models to facilitate implementation.
States that already have the CenteringPregnancy model of Group Prenatal Care
On behalf of a coalition of leading global manufacturers of blood glucose monitoring systems, McDermottPlus successfully advanced legislation intended to improve market access and patient choice under the Medicare Competitive Bidding Program.
Reduction in Medicare payment amount for diabetes test strips since 2012
Dedicated resource libraries for clients and partner organizations.
A library of content about Medicare payment transformation initiatives. Includes original analysis, major regulations, agency guidance, program announcements and other primary source documents.
A collection of primary source materials about laboratory diagnostics regulation and payment, including original analysis, Medicare rates, rulemakings, final determinations and other items of interest.
Health Reform 2.0
A collection of primary source content about the Affordable Care Act and efforts to repeal and replace the law.
Analyzes quantitative data and evaluates economic impact.
Advises clients on reimbursement and policy strategy.
Advises clients on reimbursement policy strategy.
A board certified internal medicine physician and lawyer who is recognized as a Medicare law and policy authority.
Extensive contacts and deep understanding of federal health policies.
A recognized Medicare law and policy authority and registered lobbyist.
Analyzes quantitative data and evaluates the economic impact.
A highly experienced Medicare veteran and former CMS director.
An accomplished health care executive with a deep understanding of federal health care law and policy.
A highly experienced government relations and legislative affairs strategist and advocate.